Information  X 
Enter a valid email address

Faron Pharma OY Ord NPV (DI) (FARN)

Date Time Source Announcement
16 May 2018 5:53 pm
RNS
PDMR Shareholding
15 May 2018 3:14 pm
RNS
Director/PDMR Shareholding
  2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  1:16 pm
RNS
Holdings in Company
11 May 2018 4:51 pm
RNS
Holding(s) in Company
  1:37 pm
RNS
Holding(s) in Company
  1:34 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Update on the Phase III INTEREST trial
10 May 2018 10:05 am
RNS
Notice of AGM
09 May 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
  12:54 pm
RNS
Holdings in Company
08 May 2018 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Top line data from the Phase III INTEREST trial
  7:00 am
RNS
Final Results for the year ended 31 December 2017
25 Apr 2018 12:43 pm
RNS
Holdings in Company
21 Mar 2018 7:00 am
RNS
Notice of Full Year Results
06 Mar 2018 12:54 pm
RNS
Holding(s) in Company
05 Mar 2018 10:12 am
RNS
Holding(s) in Company
02 Mar 2018 1:30 pm
RNS
Holding(s) in Company
  1:25 pm
RNS
Holding(s) in Company
01 Mar 2018 12:42 pm
RNS
Holdings in Company
  12:41 pm
RNS
Holdings in Company
26 Feb 2018 1:37 pm
RNS
Issue of Equity
21 Feb 2018 3:31 pm
RNS
Results of Placing & Issue of Equity
  7:00 am
RNS
Faron hosts R&D Day today in London
16 Feb 2018 7:00 am
RNS
Proposed Placing to raise up to �15m
05 Feb 2018 7:00 am
RNS
Second Traumakine manufacturing site established
01 Feb 2018 7:00 am
RNS
Faron Announces Clevegen Grant of European Patent
29 Jan 2018 7:00 am
RNS
FDA grants Fast Track Designation for Traumakine?
24 Jan 2018 7:00 am
RNS
FDA approval of Faron's Traumakine? IND
19 Dec 2017 7:00 am
RNS
INFORAAA trial receives recommendation from IDMC
14 Dec 2017 7:00 am
RNS
Faron announces R&D Day in February 2018
11 Dec 2017 7:32 am
RNS
Recruitment completed in Traumakine INTEREST Trial
06 Dec 2017 6:06 pm
RNS
Holding(s) in Company
01 Dec 2017 2:55 pm
RNS
Holdings in Company
  7:01 am
RNS
Appointment of Chief Commercial Officer
24 Nov 2017 10:23 am
RNS
Holding(s) in Company
21 Nov 2017 7:00 am
RNS
Grant of options
20 Nov 2017 7:00 am
RNS
Change of Adviser
16 Oct 2017 9:00 am
RNS
Holding(s) in Company
13 Oct 2017 9:00 am
RNS
Director/PDMR Shareholding
11 Oct 2017 2:00 pm
RNS
Issue of Equity & PDMR Shareholding
09 Oct 2017 4:30 pm
RNS
Result of Placing & Subscription & Issue of Equity
05 Oct 2017 7:00 am
RNS
Proposed Placing and Subscription
02 Oct 2017 7:00 am
RNS
Traumakine Receives PIM Designation from MHRA
11 Sep 2017 3:19 pm
RNS
Directors Dealings
06 Sep 2017 7:00 am
RNS
Interim Results
04 Sep 2017 7:00 am
RNS
FDA advises Faron to proceed directly to BLA
04 Aug 2017 7:00 am
RNS
Update on INTEREST Phase III Study from IDMC
28 Jul 2017 9:34 am
RNS
Holding(s) in Company
10 Jul 2017 4:51 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Notice of Results
16 Jun 2017 2:43 pm
RNS
Director/PDMR Shareholding
01 Jun 2017 7:00 am
RNS
Exercise of Warrants and Options
30 May 2017 2:06 pm
RNS
Holdings in Company
22 May 2017 11:31 am
RNS
Director/PDMR Shareholding
  7:00 am
RNS
Director/PDMR Shareholding
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t